SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study
Cost is a major barrier to accessibility in the US, where the price of medications and healthcare services are often much higher than internationally
Studies focusing on areas like 'Arm Laxity and Loss of Tone' (using Sofwave liftHD and Pure Impact) are showing remarkable promise in strengthening, toning, and improving skin laxity in the treated areas
In WD mice which had undergone subdiaphragmatic vagotomy (Supplementary Fig
Exendin-4 protected against cognitive dysfunction in hyperglycemic mice receiving an intrahippocampal lipopolysaccharide injection
Having people stop using drugs that have helped them lose weight would be like having someone stop their blood pressure medication after it brought their blood pressure down, Azagury says, or telling someone whos diabetic, but who has normalized their blood sugar with treatment, to stop their medications and wait for their blood sugar to go back up